Billionaire investor Antonio Gracias has launched a bid to take control of MDMA drug developer Lykos Therapeutics via $100M of funding and a closer alliance to its nonprofit progenitor, MAPS. Gracias heads up Valor Equity Partners, an investment firm with more than $15 billion in assets under management. It accumulated that pile of cash in large part through early bets on companies…

Source

Previous articleCan Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic Law